enVVeno Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
enVVeno Medical Corp (NVNO) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 11.00 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-03-26
- enVVeno Medical Corp share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 11.00K shares, a 99.90% decline from fiscal 2023.
- enVVeno Medical Corp share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2023 was 10.89M shares, a 14418.98% increase from fiscal 2022.
- enVVeno Medical Corp share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2022 was 75.00K shares, a 100.00% decline from fiscal 2021.
- enVVeno Medical Corp share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2021 was 4.90B shares, a 287366.95% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month as first filed |
|---|---|---|
| 2024-12-31 | 11.00K shares 10-K · filed 2026-03-26 | 379.61K shares 10-K · filed 2025-02-28 |
| 2023-12-31 | 10.89M shares 10-K · filed 2025-02-28 | |
| 2022-12-31 | 75.00K shares 10-K · filed 2024-02-29 | 75.00M shares 10-K · filed 2023-03-02 |
| 2021-12-31 | 4.90B shares 10-K · filed 2023-03-02 | 4.90M shares 10-K · filed 2022-03-28 |
| 2020-12-31 | 1.70M shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |